Zobrazeno 1 - 10
of 914
pro vyhledávání: '"N. Berman"'
Autor:
Arthur Shiyovich, Adam N. Berman, Stephanie A. Besser, David W. Biery, Rhanderson Cardoso, Sanjay Divakaran, Avinainder Singh, Daniel M. Huck, Brittany Weber, Jorge Plutzky, Christopher Cannon, Khurram Nasir, Marcelo F. Di Carli, James L. Januzzi, Deepak L. Bhatt, Ron Blankstein
Publikováno v:
Cardiovascular Diabetology, Vol 23, Iss 1, Pp 1-10 (2024)
Abstract Background Diabetes mellitus (DM) and Lp(a) are well-established predictors of coronary artery disease (CAD) outcomes. However, their combined association remains poorly understood. Objective To investigate the relationship between elevated
Externí odkaz:
https://doaj.org/article/47e85525f26e4a1dbdccab413793377c
Autor:
Sergey V. Prykhozhij, Kevin Ban, Zane L. Brown, Kim Kobar, Gabriel Wajnberg, Charlotte Fuller, Simi Chacko, Jacynthe Lacroix, Nicolas Crapoulet, Craig Midgen, Adam Shlien, David Malkin, Jason N. Berman
Publikováno v:
Data in Brief, Vol 57, Iss , Pp 111041- (2024)
Zebrafish (Danio rerio) are a good model for cancer research including studies on chemotherapy treatments. We treated wild-type and miR-34a deletion mutant zebrafish embryos at 24 h post-fertilization with 1 µM of the topoisomerase I inhibitor, camp
Externí odkaz:
https://doaj.org/article/2cf8347037df4b95a919db3322c6fd21
Autor:
Sarada Ketharnathan, Jason N. Berman
Publikováno v:
Haematologica, Vol 999, Iss 1 (2024)
Not available.
Externí odkaz:
https://doaj.org/article/adc5d3f7a28e4395b6145d53880c9e03
Autor:
Gurleen Kaur, Khaled Abdelrahman, Adam N. Berman, David W. Biery, Arthur Shiyovich, Daniel Huck, Michael Garshick, Ron Blankstein, Brittany Weber
Publikováno v:
American Journal of Preventive Cardiology, Vol 18, Iss , Pp 100641- (2024)
The strong association between lipoprotein (a) [Lp(a)] and atherosclerotic cardiovascular disease has led to considerations of Lp(a) being a potential target for mitigating residual cardiovascular risk. While approximately 20 % of the population has
Externí odkaz:
https://doaj.org/article/3d68ed3ce90242d38eadb78ff0433abb
Autor:
Arthur Shiyovich, Adam N. Berman, Stephanie A. Besser, David W. Biery, Gurleen Kaur, Sanjay Divakaran, Avinainder Singh, Daniel M. Huck, Brittany Weber, Jorge Plutzky, Marcelo F. Di Carli, Khurram Nasir, Christopher Cannon, James L. Januzzi, Deepak L. Bhatt, Ron Blankstein
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 13, Iss 10 (2024)
Background Lipoprotein (a) [Lp(a)] is a robust predictor of coronary heart disease outcomes, with targeted therapies currently under investigation. We aimed to evaluate the association of high Lp(a) with standard modifiable risk factors (SMuRFs) for
Externí odkaz:
https://doaj.org/article/f85d2353240d48e28b9e6216ffaadeed
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 13, Iss 7 (2024)
Background Many individuals eligible for statin therapy decline treatment, often due to fear of adverse effects. Misinformation about statins is common and drives statin reluctance, but its prevalence on social media platforms, such as Twitter (now X
Externí odkaz:
https://doaj.org/article/0884cfb7617c4ef3ba1cc3de5656eb17
Publikováno v:
Cogent Psychology, Vol 10, Iss 1 (2023)
AbstractMost of us understand that our rationality is bounded by our cognitive limitations, knowledge, set of beliefs, etc. Generally, however, people are not sufficiently aware of their own bounded rationality and demonstrate overprecision vis-à-vi
Externí odkaz:
https://doaj.org/article/1d02375215444d42bb02c4f5dc83c90a
Autor:
Gurleen Kaur, MD, Adam N. Berman, MD, David W. Biery, MD, Wanda Y. Wu, MD, Stephanie A. Besser, MS, Brittany Weber, MD, Marcelo Di Carli, MD, Deepak L. Bhatt, MD, Ron Blankstein, MD
Publikováno v:
American Journal of Preventive Cardiology, Vol 15, Iss , Pp 100570- (2023)
Therapeutic Area: ASCVD/CVD in Women Background: Lipoprotein (a) [Lp(a)] is a risk factor for atherosclerotic cardiovascular disease (ASCVD). However, sex based differences in the association of Lp(a) with myocardial infarction (MI) have not been wel
Externí odkaz:
https://doaj.org/article/be9223a60a1d416096464e69bd477e2b
Autor:
Adam Pietrobon, Julien Yockell‐Lelièvre, Nicole Melong, Laura J. Smith, Sean P. Delaney, Nadine Azzam, Chang Xue, Nishanth Merwin, Eric Lian, Alberto Camacho‐Magallanes, Carole Doré, Gabriel Musso, Lisa M. Julian, Arnold S. Kristof, Roger Y. Tam, Jason N. Berman, Molly S. Shoichet, William L. Stanford
Publikováno v:
Advanced Science, Vol 10, Iss 26, Pp n/a-n/a (2023)
Abstract Lymphangioleiomyomatosis (LAM) is a rare disease involving cystic lung destruction by invasive LAM cells. These cells harbor loss‐of‐function mutations in TSC2, conferring hyperactive mTORC1 signaling. Here, tissue engineering tools are
Externí odkaz:
https://doaj.org/article/a106fabeaeb643adbc219e24ad198f59
Autor:
Michael H Picard, Jason H Wasfy, Aditya Achanta, Michael K Hidrue, Sarah Urbut, Andrea L Axtell, Adam N Berman, Yunong Zhao, Julian Chen, Sarah Gustus
Publikováno v:
Open Heart, Vol 10, Iss 2 (2023)
Background Consensus guidelines support the use of implanted cardioverter-defibrillators (ICD) for primary prevention of sudden cardiac death in patients with either non-ischaemic or ischaemic cardiomyopathy with left ventricular ejection fraction (L
Externí odkaz:
https://doaj.org/article/6e516a97f63b4e38b5283fb3e5c8028a